The role of mast cells in cellular modifications evoked by Exendin-4 in treated wounds: a preclinical study.
Level 5 - mechanism / opinion, no new human data
Preclinical animal research without human data
PubMed 36001707 · doi:10.12968/jowc.2022.31.8.701
What was done
Sixteen mice each received two cutaneous wounds: one treated with an intradermal injection of saline (20 µl, Group 1) and the other with Exendin-4 (62 ng, Group 2). Mice were euthanised to harvest wounds at abrasion (T0), 48 hours (T1), 96 hours (T2), and 144 hours (T3). GLP-1 receptor (GLP-1R) expression was evaluated by Western blot in wound lysates, and cellular infiltration was assessed by histological and histochemical staining of cryosections.
What was found
The abstract reports no numerical values, variances, or statistical test results. Qualitatively, at T2 and T3, Exendin-4-treated wounds showed an increased mast cell degranulation index, with detection of GLP-1R, TNF-α, and HSP47 in mast cell cytoplasm. Dendritic cell density increased progressively and formed connections with vessels. Among dendritic cells at T2, M2 macrophages increased, while M1 cells expressed TGF-β; plasmacytoid dendritic cells also increased and established contacts with regulatory T cells.
Why it matters
This study outlines a cellular pathway involving early mast cell activation and immune cell recruitment through which GLP-1 receptor agonists may influence tissue repair.
Limits
The study is restricted to a small murine model (16 mice) with no human validation. The abstract reports only qualitative histological descriptions and provides no quantitative data, error bounds, p-values, or functional wound closure rates.
Cited by
- supports GLP-1 receptors are present on immune cells, specifically on mast cells.